-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, bio-omics research has been widely transformed and applied in various fields of life sciences, especially mass spectrometry-based metabolomics,
proteomics and multi-omics have attracted the attention of the academic community
.
In order to promote the development and academic exchanges in the fields of metabolomics, proteomics and multi-omics research and analysis, and promote the development of biomics research in various fields of life sciences, the Laboratory Physicians Branch of Guangdong Medical Doctor Association is scheduled to be held on August 12, 2022.
"Southern Clinical Mass Spectrometry First Multi-omics Academic Forum" will be held in Guangzhou from March to 13th!
proteomics and multi-omics have attracted the attention of the academic community
.
In order to promote the development and academic exchanges in the fields of metabolomics, proteomics and multi-omics research and analysis, and promote the development of biomics research in various fields of life sciences, the Laboratory Physicians Branch of Guangdong Medical Doctor Association is scheduled to be held on August 12, 2022.
"Southern Clinical Mass Spectrometry First Multi-omics Academic Forum" will be held in Guangzhou from March to 13th!
At that time, top experts and scholars in the industry will be invited to share and communicate, and jointly conduct in-depth discussions and learning on cutting-edge technologies and hot topics in metabolomics, proteomics and multi-omics research and analysis
.
.
The First Multi-omics Academic Forum of Southern Clinical Mass Spectrometry
meeting time
Registration time: 14:00-17:00 on August 12, 2022; 07:30-09:00 on August 13
Forum time: August 13, 2022 09:00-17:00
meeting place
Mehood Lestie Hotel Guangzhou East Railway Station (No.
167, Linhe West Road, Tianhe District, Guangzhou)
167, Linhe West Road, Tianhe District, Guangzhou)
meeting organization
Sponsor: Laboratory Physician Branch of Guangdong Medical Doctor Association
Organizer: Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University
Co-organizers: Shanghai Baiqu Metabolomics Technology Research Center, Southern Clinical Mass Spectrometry Alliance
Expert introduction of conference report
Professor Zheng Lei, Southern Hospital of Southern Medical University
Doctoral tutor, winner of the National Science Fund for Distinguished Young Scholars, director of the Laboratory Department of Nanfang Hospital of Southern Medical University, director of the Guangdong Provincial Engineering Research Center for Rapid Diagnosis of Biosensing Technology
.
He is the executive committee member of the International Society for Extracellular Vesicles, the standing committee member of the Chinese Medical Association Laboratory Branch, the chairman of the Laboratory Physician Branch of the Guangdong Medical Association, and the tenth chairman of the Guangdong Medical Association Laboratory Branch
.
The main research directions are research on new technologies for the discovery and detection of major disease markers, experimental diagnosis of thrombosis and hemostasis, and informatization research on inspection and education
.
Undertook more than ten scientific research projects of the National Natural Science Foundation of China, the AACC CPOCT project of the United States, and the provincial and ministerial level.
He has published more than 40 SCI papers in internationally renowned journals, including 12 papers in Zone I and 6 national invention patents
.
He has won 2 first prizes for teaching achievements in Guangdong Province, and is the deputy editor of 8 textbooks and monographs
.
.
He is the executive committee member of the International Society for Extracellular Vesicles, the standing committee member of the Chinese Medical Association Laboratory Branch, the chairman of the Laboratory Physician Branch of the Guangdong Medical Association, and the tenth chairman of the Guangdong Medical Association Laboratory Branch
.
The main research directions are research on new technologies for the discovery and detection of major disease markers, experimental diagnosis of thrombosis and hemostasis, and informatization research on inspection and education
.
Undertook more than ten scientific research projects of the National Natural Science Foundation of China, the AACC CPOCT project of the United States, and the provincial and ministerial level.
He has published more than 40 SCI papers in internationally renowned journals, including 12 papers in Zone I and 6 national invention patents
.
He has won 2 first prizes for teaching achievements in Guangdong Province, and is the deputy editor of 8 textbooks and monographs
.
Professor Tian Ruijun, Southern University of Science and Technology
Tenured professor of the Department of Chemistry, Southern University of Science and Technology, winner of the National Outstanding Youth Fund, vice chairman of the China Proteome Organization CNHUPO, director of the Chromatography Professional Committee of the Chinese Chemical Society, standing member of the National Chromatography Academic Committee, director of the Chinese Society for Mass Spectrometry and Chinese Molecular Systems Biology Director of the Society, Director of the Special Sub-Project of Protein Machines in the National Key R&D Program of the Ministry of Science and Technology
.
He is devoted to the methodological and applied research of proteomics, and carries out applied research in the biomedical directions such as cell signal transduction and tumor microenvironment
.
He has published nearly 100 papers in international mainstream academic journals, among which he has published more than 60 papers in Nature, Nat.
Commun, PNAS, Mol.
Cell.
Proteomics, Anal.
Chem, Angew Chem, etc.
, as a guest editor A special issue
.
He has served as the co-executive chairman of the 23rd National Chromatography Society of the Chinese Chemical Society, the co-chair of the 5th China-Canada Systems Biology Symposium and the 2nd China Proteome Organization (CNHUPO) Young Scholars Symposium
.
Served as the young editorial board member of the Chromatography Journal and the editorial board member of the international journal Frontiers in Endocrinology
.
.
He is devoted to the methodological and applied research of proteomics, and carries out applied research in the biomedical directions such as cell signal transduction and tumor microenvironment
.
He has published nearly 100 papers in international mainstream academic journals, among which he has published more than 60 papers in Nature, Nat.
Commun, PNAS, Mol.
Cell.
Proteomics, Anal.
Chem, Angew Chem, etc.
, as a guest editor A special issue
.
He has served as the co-executive chairman of the 23rd National Chromatography Society of the Chinese Chemical Society, the co-chair of the 5th China-Canada Systems Biology Symposium and the 2nd China Proteome Organization (CNHUPO) Young Scholars Symposium
.
Served as the young editorial board member of the Chromatography Journal and the editorial board member of the international journal Frontiers in Endocrinology
.
Professor Dai Yong, Shenzhen People's Hospital
Chief physician of the Department of Nephrology (Secondary), professor of internal medicine, researcher of biomedical engineering, doctoral student, postdoctoral supervisor
.
One of Elsevier's 2020 and 2021 Highly Cited Scholars in China and the world's top scientists
.
Undertook and participated in 82 research projects at all levels; authorized 31 national invention patents
.
Published 769 papers at home and abroad, of which 269 were mainly published by the first author or corresponding author and were included in SCI.
The total number of citations exceeded 6022, of which the highest single citation was 442, and the H index was 36
.
He has edited or participated in the compilation of 9 monographs; won 28 scientific research achievement awards, including 1 national second prize for scientific and technological progress, 12 provincial and ministerial scientific research achievement awards, and 12 awards for the first person in charge of the project
.
.
One of Elsevier's 2020 and 2021 Highly Cited Scholars in China and the world's top scientists
.
Undertook and participated in 82 research projects at all levels; authorized 31 national invention patents
.
Published 769 papers at home and abroad, of which 269 were mainly published by the first author or corresponding author and were included in SCI.
The total number of citations exceeded 6022, of which the highest single citation was 442, and the H index was 36
.
He has edited or participated in the compilation of 9 monographs; won 28 scientific research achievement awards, including 1 national second prize for scientific and technological progress, 12 provincial and ministerial scientific research achievement awards, and 12 awards for the first person in charge of the project
.
Professor Yu Jun, Chinese University of Hong Kong
Li Zhuomin Chair Professor, Department of Internal Medicine and Therapeutics, Chinese University of Hong Kong, Director of the State Key Laboratory of Digestive Disease Research, Director of the Institute of Digestive Diseases, and Assistant Dean of the Faculty of Medicine
.
Long-term commitment to the mechanism of digestive system tumorigenesis and related microecological research
.
Published more than 500 academic papers (ISI cited more than 26,000 times, ISI H-index 85, Google H-index 106), of which 176 were IF above 10 and 84 were IF above 20
.
He has won 36 awards including the second prize of the National Natural Science Award in 2020 and 2016, and the 2018 Ho Leung Ho Lee Foundation Science and Technology Progress Award
.
25 patents have been authorized, among which the early screening markers for colorectal cancer and gastric cancer have been approved by the State Food and Drug Administration for clinical testing
.
Invited more than 220 lectures at international conferences
.
.
Long-term commitment to the mechanism of digestive system tumorigenesis and related microecological research
.
Published more than 500 academic papers (ISI cited more than 26,000 times, ISI H-index 85, Google H-index 106), of which 176 were IF above 10 and 84 were IF above 20
.
He has won 36 awards including the second prize of the National Natural Science Award in 2020 and 2016, and the 2018 Ho Leung Ho Lee Foundation Science and Technology Progress Award
.
25 patents have been authorized, among which the early screening markers for colorectal cancer and gastric cancer have been approved by the State Food and Drug Administration for clinical testing
.
Invited more than 220 lectures at international conferences
.
Dr.
Zhu Lin, Hong Kong Baptist University
Zhu Lin, Hong Kong Baptist University
Ph.
D.
, Department of Biology, Hong Kong University of Science and Technology, Scientific Director, State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University
.
The main research direction is the analysis and application of proteomics and post-translational modification
.
He has published 12 papers in The Innovation, CCS Chemistry, Mol Cell Proteomics, Small Structure, Talanta, etc.
as the first or corresponding author, and published papers in Cell, Environ.
Small Methods, Gastroenterology and other journals as a co-author
.
Presided over a NSFC Youth Fund; participated in a special project of science and technology innovation cooperation between Hong Kong, Macao and Taiwan of the Ministry of Science and Technology
.
In 2020, he won the special prize of China Association for Analysis and Testing Science and Technology Award (CAIA Award)
.
D.
, Department of Biology, Hong Kong University of Science and Technology, Scientific Director, State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University
.
The main research direction is the analysis and application of proteomics and post-translational modification
.
He has published 12 papers in The Innovation, CCS Chemistry, Mol Cell Proteomics, Small Structure, Talanta, etc.
as the first or corresponding author, and published papers in Cell, Environ.
Small Methods, Gastroenterology and other journals as a co-author
.
Presided over a NSFC Youth Fund; participated in a special project of science and technology innovation cooperation between Hong Kong, Macao and Taiwan of the Ministry of Science and Technology
.
In 2020, he won the special prize of China Association for Analysis and Testing Science and Technology Award (CAIA Award)
.
Associate Researcher Hu Wei, Shenzhen Hospital of Southern Medical University
An associate researcher at Shenzhen Hospital of Southern Medical University, a high-level overseas talent in Shenzhen, and a high-level talent in Bao'an District
.
In 2017, he obtained a doctorate in biomedicine from the Chinese University of Hong Kong.
In January 2019, he joined the Department of Gastroenterology, Shenzhen Hospital of Southern Medical University, as a full-time research PI
.
Up to now, he has presided over a number of national and provincial natural science funds and published more than 40 SCI papers
.
Among them, 13 SCI papers were published as the first or corresponding author, and the research results were published in world-renowned medical journals such as Autophagy, Theranostics, Cancer Research, Acta Pharmaceutica Sinica B, Cancer Letters, Journal of Pathology, Seminars in Cell&Developmental Biology, etc.
The total citation of the article More than a thousand times
.
.
In 2017, he obtained a doctorate in biomedicine from the Chinese University of Hong Kong.
In January 2019, he joined the Department of Gastroenterology, Shenzhen Hospital of Southern Medical University, as a full-time research PI
.
Up to now, he has presided over a number of national and provincial natural science funds and published more than 40 SCI papers
.
Among them, 13 SCI papers were published as the first or corresponding author, and the research results were published in world-renowned medical journals such as Autophagy, Theranostics, Cancer Research, Acta Pharmaceutica Sinica B, Cancer Letters, Journal of Pathology, Seminars in Cell&Developmental Biology, etc.
The total citation of the article More than a thousand times
.
Dr.
Luo Xiao, University of Bielefeld, Germany
Luo Xiao, University of Bielefeld, Germany
Ph.
D.
in Bioinformatics, Young Editorial Board Member of iMeta Magazine, Graduated from Bielefeld University, Germany
.
His research interests include computational genomics and microbiome data mining
.
During his Ph.
D.
, he developed multiple haplotype genome assembly methods and tools, including diploid, viral subspecies, and metagenomic assembly
.
Published several papers in internationally renowned journals, such as: Genome Biology, Nucleic Acids Research, Nature Communications, Bioinformatics,
etc.
He has reviewed papers for several international conferences on bioinformatics, such as ISMB/ECCB, RECOMB, WABI,
etc.
D.
in Bioinformatics, Young Editorial Board Member of iMeta Magazine, Graduated from Bielefeld University, Germany
.
His research interests include computational genomics and microbiome data mining
.
During his Ph.
D.
, he developed multiple haplotype genome assembly methods and tools, including diploid, viral subspecies, and metagenomic assembly
.
Published several papers in internationally renowned journals, such as: Genome Biology, Nucleic Acids Research, Nature Communications, Bioinformatics,
etc.
He has reviewed papers for several international conferences on bioinformatics, such as ISMB/ECCB, RECOMB, WABI,
etc.
Participants
Experts and scholars engaged in metabolomics, proteomics and multi-omics research and analysis
.
.
Conference fee
free registration
ways of registration
Search the public account of "Aqu Metabolomics" on WeChat and follow it, and reply to "Forum Registration" in the background to scan the code and fill in the registration information
